These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


244 related items for PubMed ID: 16631124

  • 1. Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity.
    Yáñez M, Fraiz N, Cano E, Orallo F.
    Biochem Biophys Res Commun; 2006 Jun 02; 344(2):688-95. PubMed ID: 16631124
    [Abstract] [Full Text] [Related]

  • 2. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
    Yáñez M, Fraiz N, Cano E, Orallo F.
    Eur J Pharmacol; 2006 Aug 07; 542(1-3):54-60. PubMed ID: 16828740
    [Abstract] [Full Text] [Related]

  • 3. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP, Galva MD, Villa F, Sciaba L, Picotti GB.
    Biochem Pharmacol; 1995 Jun 29; 50(1):97-102. PubMed ID: 7605351
    [Abstract] [Full Text] [Related]

  • 4. The 5-hydroxytryptamine-releasing properties of two epimer quinoline derivatives.
    Le Fur G, Imbault F, Mitrani N, Marquis F, Renault C, Dubroeucq MC, Gueremy C, Uzan A.
    Neuropharmacology; 1984 Feb 29; 23(2A):169-73. PubMed ID: 6717757
    [Abstract] [Full Text] [Related]

  • 5. Effect of monoamine oxidase A and B inhibition on the uptake and metabolism of serotonin within serotonergic neurons of rat brain.
    Shim SS, Becker RE.
    J Psychopharmacol; 1993 Jan 29; 7(2):181-9. PubMed ID: 22290665
    [Abstract] [Full Text] [Related]

  • 6. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH, Günzler WA, Flohé L.
    Arzneimittelforschung; 1984 Jan 29; 34(11):1471-80. PubMed ID: 6084511
    [Abstract] [Full Text] [Related]

  • 7. Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences.
    Yu Y, Wang R, Chen C, Du X, Ruan L, Sun J, Li J, Zhang L, O'Donnell JM, Pan J, Xu Y.
    J Psychiatr Res; 2013 Mar 29; 47(3):315-22. PubMed ID: 23174668
    [Abstract] [Full Text] [Related]

  • 8. "In vitro" effect of some 5-hydroxy-indolalkylamine derivatives on monoamine uptake system.
    Morón JA, Perez V, Fernández-Alvarez E, Marco JL, Unzeta M.
    J Neural Transm Suppl; 1998 Mar 29; 52():343-9. PubMed ID: 9564637
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M, García-Sevilla JA.
    Br J Pharmacol; 1997 Jul 29; 121(5):901-12. PubMed ID: 9222546
    [Abstract] [Full Text] [Related]

  • 10. Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercury.
    Chakrabarti SK, Loua KM, Bai C, Durham H, Panisset JC.
    Neurotoxicol Teratol; 1998 Jul 29; 20(2):161-8. PubMed ID: 9536461
    [Abstract] [Full Text] [Related]

  • 11. Effect of acute and chronic tramadol on [3H]-5-HT uptake in rat cortical synaptosomes.
    Giusti P, Buriani A, Cima L, Lipartiti M.
    Br J Pharmacol; 1997 Sep 29; 122(2):302-6. PubMed ID: 9313939
    [Abstract] [Full Text] [Related]

  • 12. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish.
    Sallinen V, Sundvik M, Reenilä I, Peitsaro N, Khrustalyov D, Anichtchik O, Toleikyte G, Kaslin J, Panula P.
    J Neurochem; 2009 Apr 29; 109(2):403-15. PubMed ID: 19222706
    [Abstract] [Full Text] [Related]

  • 13. Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo.
    Southam E, Pereira R, Stratton SC, Sargent R, Ford AJ, Butterfield LJ, Wheable JD, Beckett SR, Roe C, Marsden CA, Hagan RM.
    Eur J Pharmacol; 2005 Sep 20; 519(3):237-45. PubMed ID: 16129425
    [Abstract] [Full Text] [Related]

  • 14. Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation.
    Rius C, Abu-Taha M, Hermenegildo C, Piqueras L, Cerda-Nicolas JM, Issekutz AC, Estañ L, Cortijo J, Morcillo EJ, Orallo F, Sanz MJ.
    J Immunol; 2010 Sep 15; 185(6):3718-27. PubMed ID: 20709957
    [Abstract] [Full Text] [Related]

  • 15. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
    Bour S, Iglesias-Osma MC, Marti L, Duro P, Garcia-Barrado MJ, Pastor MF, Prévot D, Visentin V, Valet P, Moratinos J, Carpéné C.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):20-30. PubMed ID: 17056035
    [Abstract] [Full Text] [Related]

  • 16. Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues.
    Harvey BH, Duvenhage I, Viljoen F, Scheepers N, Malan SF, Wegener G, Brink CB, Petzer JP.
    Biochem Pharmacol; 2010 Nov 15; 80(10):1580-91. PubMed ID: 20699087
    [Abstract] [Full Text] [Related]

  • 17. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T, Aomine M.
    Res Commun Mol Pathol Pharmacol; 2010 Nov 15; 122-123(1-6):13-26. PubMed ID: 22032088
    [Abstract] [Full Text] [Related]

  • 18. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury.
    Bianchi P, Kunduzova O, Masini E, Cambon C, Bani D, Raimondi L, Seguelas MH, Nistri S, Colucci W, Leducq N, Parini A.
    Circulation; 2005 Nov 22; 112(21):3297-305. PubMed ID: 16286591
    [Abstract] [Full Text] [Related]

  • 19. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats.
    Southam E, Kirkby D, Higgins GA, Hagan RM.
    Eur J Pharmacol; 1998 Sep 25; 358(1):19-24. PubMed ID: 9809864
    [Abstract] [Full Text] [Related]

  • 20. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine.
    Kitaichi Y, Inoue T, Nakagawa S, Boku S, Izumi T, Koyama T.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):77-82. PubMed ID: 20406628
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.